Updated: iRhythm Continues To Grow Despite Reimbursement, Hospital-Staffing Challenges

CMS' Decision To Punt Remote Monitoring Payment To 2023 Disappoints iRhythm Again

Despite intense lobbying from industry and physician groups, CMS chose not to install national pricing for long-term remote cardiac monitoring in its final 2022 Medicare Physician Fee Schedule Final Rule.

Zio XT Patch Side View
IRHYTHM'S ZIO XT ECG MONITOR • Source: iRhythm Technologies, Inc.

[Editor's note: This article was updated on 5 November to include comments from iRhythm's management during its 4 November earnings call.]

Remote cardiac monitoring companies must continue working with local Medicare carriers to secure higher reimbursement rates for long-term remote monitoring...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Policy & Regulation

More from Medtech Insight